Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms

Modern Pathology

Volumn 21, Issue 2, 2008, Pages 192-200

  Nonaka, Daisuke ^a   Tang, Yunjia ^a   Chiriboga, Luis ^a   Rivera, Michael ^b   Ghossein, Ronald ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anaplastic thyroid carcinoma; FoxE1; Pax8; Thyroid neoplasms; TTF 1; TTF 2

Indexed keywords

THYROID TRANSCRIPTION FACTOR 1; THYROID TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR PAX8;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUBULE; LUNG CARCINOMA; LYMPH FOLLICLE; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; NEPHROBLASTOMA; OVARY CARCINOMA; OVARY CYST; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA; THYROID TUMOR; UTERINE TUBE;

ADENOCARCINOMA; ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; DNA-BINDING PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PAIRED BOX TRANSCRIPTION FACTORS; THYROID GLAND; THYROID NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 38649127254     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3801002     Document Type: Article

References (44)

1. Zhang P, Zuo H, Nakamura Y, et al. Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 2006;56:240-245.
2. DeLellis R, Williams E. Tumours of the thyroid and parathyroid. In: DeLellis R, Lloyd R, Heitz P, Eng C (eds). Pathology & Genetics, Tumours of Endocrine Organs, 1st edn. IARC Press: Lyon, 2004, pp 49-133.
3. Rosai J. Thyroid gland. In: Rosai J (ed). Rosai and Ackerman's Surgical Pathology, 9th edn. Mosby: London, UK, 2004, pp 515-594.
4. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847.
5. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-1251.
6. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
7. Mazzaferri E. Thyroid carcinoma: papillary and follicular. In: Mazzaferri E, Samaan N (eds). Endocrine Tumors. Blackwell Scientific Publications Inc.: Cambridge, MA, 1993, pp 278-333.
8. Colby T, Koss M, Travis W. Carcinoma of the lung; clinical, radiographic aspects, spread, staging, management, and prognosis. In: Colby T, Koss M, Travis W (eds). Tumors of the Lower Respiratory Tract, 3rd series edn. Armed forces institute of pathology: Washington, DC, 1995, pp 107-134.
9. Lin JD, Weng HF, Ho YS. Clinical and pathological characteristics of secondary thyroid cancer. Thyroid 1998;8:149-153.
10. Shimaoka K, Sokal JE, Pickren JW. Metastatic neoplasms in the thyroid gland. Pathological and clinical findings. Cancer 1962;15:557-565.
11. Nakhjavani MK, Gharib H, Goellner JR, et al. Metastasis to the thyroid gland. A report of 43 cases. Cancer 1997;79:574-578.
12. Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984;53:982-992.
13. Shimosato Y, Melamed M, Nettesheim P. In: Shimosato Y, Melamed M, Nettesheim P (eds). Morphogenesis of Peripheral Type Adenocarcinoma of the Lung, vol. I. CRC Press Inc.: Boca Raton, FL, 1982, pp 65-90.
14. Zamecnik J, Kodet R. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch 2002;440:353-361.
15. Katoh R, Kawaoi A, Miyagi E, et al. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Mod Pathol 2000;13:570-576.
16. Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 2002;26:767-773.
17. Bejarano PA, Nikiforov YE, Swenson ES, et al. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2000;8:189-194.
18. Carcangiu ML, Steeper T, Zampi G, et al. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 1985;83:135-158.
19. LiVolsi VA, Brooks JJ, Arendash-Durand B. Anaplastic thyroid tumors. Immunohistology. Am J Clin Pathol 1987;87:434-442.
20. Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 2003;27:311-324.
21. Miettinen M, Franssila KO. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma. Hum Pathol 2000;31:1139-1145.
22. Ponzoni M, Arrigoni G, Doglioni C. New transcription factors in diagnostic hematopathology. Adv Anat Pathol 2007;14:25-35.
23. Trueba SS, Auge J, Mattei G, et al. PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. J Clin Endocrinol Metab 2005;90:455-462.
24. Scouten WT, Patel A, Terrell R, et al. Cytoplasmic localization of the paired box gene, Pax-8, is found in pediatric thyroid cancer and may be associated with a greater risk of recurrence. Thyroid 2004;14:1037-1046.
25. Pasca dM, Di Lauro R, Zannini M. Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci USA 2000;97:13144-13149.
26. Guazzi S, Price M, De Felice M, et al. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631-3639.
27. Park SM, Chatterjee VK. Genetics of congenital hypothyroidism. J Med Genet 2005;42:379-389.
28. Sequeira M, Al Khafaji F, Park S, et al. Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis. Thyroid 2003;13:927-932.
29. Clifton-Bligh RJ, Wentworth JM, Heinz P, et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998;19:399-401.
30. Castanet M, Park SM, Smith A, et al. A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis and cleft palate. Hum Mol Genet 2002;11:2051-2059.
31. Poleev A, Fickenscher H, Mundlos S, et al. PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development 1992;116:611-623.
32. Mittag J, Winterhager E, Bauer K, et al. Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology 2007;148:719-725.
33. De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004;25:722-746.
34. Brabant G, Maenhaut C, Kohrle J, et al. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 1991;82:R7-R12.
35. Lazar V, Bidart JM, Caillou B, et al. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 1999;84:3228-3234.
36. Kusakabe T, Hoshi N, Kimura S. Origin of the ultimobranchial body cyst: T/ebp/Nkx2.1 expression is required for development and fusion of the ultimobranchial body to the thyroid. Dev Dyn 2006;235:1300-1309.
37. Suzuki M, Katagiri N, Ueda M, et al. Functional analysis of Nkx2.1 and Pax9 for calcitonin gene transcription. Gen Comp Endocrinol 2007;152:259-266.
38. Puglisi F, Cesselli D, Damante G, et al. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases. Anticancer Res 2000;20:311-316.
39. Sequeira MJ, Morgan JM, Fuhrer D, et al. Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid 2001;11:995-1001.
40. Katoh R, Miyagi E, Nakamura N, et al. Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas. Hum Pathol 2000;31:386-393.
41. Narlis M, Grote D, Gaitan Y, et al. Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol 2007;18:1121-1129.
42. Bowen NJ, Logani S, Dickerson EB, et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol 2007;104:331-337.
43. Are C, Shaha AR. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006;13:453-464.
44. Scagliotti G. Optimizing chemotherapy for patients with advanced non-small cell lung cancer. J Thorac Oncol 2007;2:S86-S91.